 San Francisco Chronicle | New drugs extend myeloma patients' lives San Francisco Chronicle When Stephen Barrager started on a clinical trial drug at UCSF three years ago, the cancer had ravaged his kidneys and had progressed to the point that a stem-cell transplant - which can be used to control the disease - was no longer an option. He was ... |
